Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ACELYRIN Inc SLRN

Healthcare Biotechnology
ACELYRIN, INC. is a late-stage clinical biopharma company. The Company is focused on providing treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The Company has two programs in late-stage clinical development. The Company’s lead product candidate, izokibep, is being evaluated in multiple immunologic indications... see more

Recent & Breaking News (NDAQ:SLRN)

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses of $100,000 to Contact the Firm

Accesswire January 3, 2024

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Acelyrin, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SLRN

Accesswire January 2, 2024

SLRN Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed against Acelyrin, Inc. (SLRN)

Accesswire January 2, 2024

SLRN 2-WEEK DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages SLRN Investors with Substantial Losses to Contact Firm Before Jan. 16th Deadline in Securities Fraud Lawsuit

Newsfile January 2, 2024

ACELYRIN, Inc. (SLRN) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by January 16, 2024

Newsfile January 2, 2024

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Acelyrin, Inc. (SLRN) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire January 2, 2024

SLRN Investors Have Opportunity to Lead ACELYRIN, Inc. Securities Fraud Lawsuit

PR Newswire January 2, 2024

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses of $100,000 to Contact the Firm

Newsfile January 2, 2024

ROSEN, A RESPECTED AND LEADING FIRM, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SLRN

TheNewsWire January 2, 2024

INVESTOR ALERT: Levi & Korsinsky Reminds Acelyrin, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2024 - SLRN

Accesswire January 2, 2024

INVESTOR ALERT: Levi & Korsinsky Notifies Acelyrin, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SLRN

Accesswire January 2, 2024

SLRN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds ACELYRIN, Inc. Investors with Substantial Losses to Contact the Firm!

Accesswire January 2, 2024

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Acelyrin, Inc.(SLRN) Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire January 2, 2024

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Acelyrin, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SLRN

Accesswire January 1, 2024

SHAREHOLDER ACTION DEADLINE: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses to Contact the Firm

Accesswire January 1, 2024

INVESTOR ALERT: Potential Recovery for Acelyrin, Inc. (SLRN) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit

Accesswire January 1, 2024

ROSEN, A LEADING NATIONAL FIRM, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SLRN

PR Newswire January 1, 2024

Acelyrin Deadline Alert

Newsfile January 1, 2024

INVESTOR ALERT: Levi & Korsinsky Notifies Shareholders of Acelyrin, Inc.(SLRN) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire January 1, 2024

Kessler Topaz Meltzer & Check, LLP Reminds Acelyrin, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors to Contact the Firm

Newsfile January 1, 2024